Collegium Pharmaceutical, Inc. COLL Belbuca — Thereafter
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s belbuca — thereafter.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s belbuca — thereafter?
- Collegium Pharmaceutical, Inc. (COLL) reported belbuca — thereafter of $0 in Q1 2026.
- What does belbuca — thereafter mean?
- Represents the projected future revenue or financial obligations associated with the Belbuca product line beyond the standard five-year reporting window. This metric helps investors assess the long-term sustainability and terminal value of the product's market lifecycle. It is critical for modeling the tail-end cash flows of specialty pharmaceutical assets.